Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
NCT02562118
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Lenvatinib + Letrozole
Sponsor
National University Hospital, Singapore
Collaborators
[object Object]